BioMan4R2 Success stories Gate2Brain

Submitted by Margot Jehle on 17 May 2024


πŸ… Gate2Brain was one of the awarded companies within the π˜½π™π™Žπ™„π™‰π™€π™Žπ™Ž π™π™π˜Όπ™‰π™Žπ™π™Šπ™π™ˆπ˜Όπ™π™„π™Šπ™‰ category: a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier.

"At G2B we had a dream, to cross barriers and bring medicines beyond them. G2B has developed a peptide-based patented technology that help drugs from different natures to cross the Blood Brain Barrier (BBB) and reach the brain. 1/4 of us will suffer from a Central Nervous System disease during our life. There are promising drug candidates for most diseases but 98% of them fail crossing the BBB. π†πŸπ-𝟎𝟎𝟐 is a therapeutic opportunity to fight against pediatric brain tumors. We have achieved promising evidence on the therapeutic efficacy of π†πŸπ-𝟎𝟎𝟐 in orthotopic patient derived animal models of brain tumors in terms of tumor reduction and increase survival."

We would like to express our gratitude to Gate2Brain for their valuable testimonial. πŸ™ Congratulations for your achievements! πŸŽ‰

Attachment Size
GATE2BRAIN_1715943701.pdf 1.06 MB
Share this Article